Student Name
Capella University
NURS-FPX4015 Pathophysiology, Pharmacology, and Physical Assessment: A Holistic Approach to Patient-Centered Care
Prof. Name
Date
Comprehensive Head-to-Toe Assessment
This assessment provides an in-depth evaluation of the patient’s health status by integrating subjective symptoms, objective clinical findings, and overall well-being. In addition to standard physical examination, we reviewed the patient’s blood glucose levels, cardiovascular status, and foot health. These evaluations are crucial for identifying complications that may arise from diabetes, particularly concerning circulation and nerve function. Early detection allows for interventions that promote health while preventing harm. The findings from this assessment will inform a personalized support care plan tailored to the patient’s needs and goals.
Introduction to Assessment
Hello, I am your nurse today. This video-based evaluation will guide you through each component of a head-to-toe assessment. I will ask you to demonstrate certain actions or describe symptoms so that I can gain a comprehensive understanding of your current health.
You appear alert, oriented, and communicate effectively. You report obtaining approximately 8 hours of sleep nightly. Recent home vital signs include blood pressure readings averaging 140/85 mmHg and a heart rate between 78–82 bpm. Blood glucose readings at home have ranged between 130–140 mg/dL, and your last hemoglobin A1C was 8.9%.
Your medical history includes hypertension, hyperlipidemia, and newly diagnosed type 2 diabetes mellitus. Current medications include metoprolol 50 mg twice daily, atorvastatin 80 mg daily, and gabapentin for neuropathic pain. You also take Tung seed as a herbal supplement. Family history reveals significant cardiovascular and metabolic disorders: your mother has a history of alcoholism, hyperlipidemia, and diabetes; your father has hypertension and high cholesterol; paternal grandfather experienced diabetes with left leg amputation; and maternal grandfather had diabetes requiring dialysis.
Lifestyle factors include moderate physical activity, such as 30-minute walks on weekends, and a mixed diet containing both canned and fast foods.
Physical Examination Findings
Eyes and Oral Cavity
Your eyes appear clear, with no signs of redness or jaundice. Vision is reported as normal, although ongoing monitoring is necessary due to diabetes-related risks. Examination of the oral cavity shows slight dryness of the tongue and lips, correlating with your increased thirst.
Neurological and Sensory Assessment
The patient reports tingling and burning sensations in both feet, with a visual analog pain scale rating of 5/10. There is decreased sensation to sharp and dull stimuli in both feet, while self-reported motor function indicates no weakness or abnormal movements. Occasional lightheadedness is noted, but dizziness is otherwise denied.
Skin, Circulation, and Extremities
Skin across the legs and feet shows normal coloration without cyanosis. Mild dryness is observed, but there are no open wounds. Pulses in the dorsalis pedis and posterior tibial arteries are present but slightly diminished. Skin temperature is warm, though toes exhibit slightly lower temperatures than upper legs, possibly indicating early ischemia. No edema is observed.
Cardiovascular Assessment
Heart rate is regular, and no chest pain, palpitations, or shortness of breath is reported. A stenotic murmur at the 4th intercostal space is noted, consistent with prior records, potentially indicating arterial narrowing.
Summary of Key Findings
| System | Observation | Clinical Significance |
|---|---|---|
| Eyes | Clear, no redness or jaundice | Vision appears intact, but diabetes requires ongoing monitoring |
| Oral cavity | Slight dryness of tongue and lips | May indicate dehydration due to hyperglycemia |
| Neurological | Tingling and burning in feet, decreased sensation | Consistent with peripheral neuropathy |
| Cardiovascular | Regular HR, BP 140/85 mmHg, stenotic murmur | Hypertension and murmur indicate increased cardiac risk |
| Skin | Mild dryness, no wounds, warm | Early ischemia noted in toes |
| Circulation | Dorsalis pedis and posterior tibial pulses palpable but diminished | Risk for peripheral arterial disease |
Discussion of Diagnosis and Findings
The combination of tingling, burning, and reduced sensation in the feet, along with elevated blood glucose and a history of hypertension and hyperlipidemia, aligns with a diagnosis of type 2 diabetes with peripheral neuropathy (Bodman & Varacallo, 2024). The patient’s hemoglobin A1C of 8.9% confirms prolonged hyperglycemia, which contributes to nerve and microvascular damage, especially in the lower extremities.
Family history of diabetes and cardiovascular disease further increases susceptibility. Neuropathy is exacerbated by poor circulation due to hypertension and hyperlipidemia (Bays, 2021). The assessment findings and patient-reported symptoms confirm the need for interventions focusing on glycemic control, vascular health, and neuropathic pain management.
Understanding of Pharmacological Needs
The treatment plan focuses on three primary goals:
- Lowering blood glucose – Metformin or other antidiabetic agents help prevent further nerve damage. Maintaining target glucose levels slows neuropathy progression (Yang et al., 2025).
- Protecting nerves – Gabapentin alleviates tingling, burning, and shooting pain associated with nerve irritation.
- Cardiovascular protection – Atorvastatin lowers cholesterol and supports vascular health, while metoprolol controls blood pressure and reduces cardiac strain.
Potential side effects include dizziness or drowsiness from gabapentin, gastrointestinal upset from metformin, and muscle aches from atorvastatin (Cleveland Clinic, 2025; Mayo Clinic, 2024). Monitoring for worsening numbness, swelling, chest pain, or severe hypoglycemia is essential.
| Medication | Purpose | Potential Side Effects |
|---|---|---|
| Metformin | Lower blood sugar | GI upset, nausea |
| Gabapentin | Relieve neuropathic pain | Dizziness, drowsiness |
| Atorvastatin | Reduce cholesterol, protect vessels | Muscle aches |
| Metoprolol | Control blood pressure | Fatigue, dizziness |
| Tung seed | Herbal supplement | Potential interactions with medications |
Education Plan
To manage diabetes, neuropathy, and cardiovascular risk:
- Medication adherence – Take medications as prescribed and report side effects.
- Lifestyle management – Monitor blood glucose daily, maintain a balanced diet, and exercise regularly to improve nerve and heart health (Yang et al., 2025).
- Foot care – Inspect feet daily, wear properly fitting shoes, and protect against injury to reduce infection risk (American Diabetes Association, 2024).
Demonstrations and patient education are key to ensuring confidence in self-care.
Understanding the Pathophysiology
Type 2 diabetes results from insulin resistance, impairing glucose uptake by cells and causing hyperglycemia (CDC, 2024). Chronic high blood sugar damages small vessels and peripheral nerves, particularly in the feet, leading to peripheral neuropathy. Symptoms include tingling, burning, and sharp pain. Prolonged hyperglycemia also affects other organs, including eyes and kidneys (Yachmaneni et al., 2023).
Critical Thinking and Clinical Reasoning: Establishing Care Priorities
Care priorities include:
- Stabilizing blood glucose levels
- Protecting nerves and circulation
- Reducing cardiovascular risk
- Promoting daily habits to prevent complications
These priorities are supported by best practices from the American Diabetes Association, emphasizing glucose control, foot care, early neuropathy detection, and cardiovascular risk management (ADA, 2023).
Conclusion
By adhering to prescribed medications, lifestyle changes, and foot care routines, the patient can manage symptoms, prevent further nerve damage, and maintain cardiovascular health. Continuous guidance ensures patient confidence and support throughout this process.
References
American Diabetes Association (ADA). (2023). American diabetes association releases 2023 standards of care in diabetes to guide prevention, diagnosis, and treatment for people living with diabetes | ADA. Diabetes.org. https://diabetes.org/newsroom/american-diabetes-association-2023-standards-care-diabetes-guide-for-prevention-diagnosis-treatment-people-living-with-diabetes
Bays, H. (2021). Ten things to know about ten cardiovascular disease risk factors. American Journal of Preventive Cardiology, 5(100149), 100149. https://doi.org/10.1016/j.ajpc.2021.100149
Bodman, M. A., & Varacallo, M. (2024). Diabetic neuropathy. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK442009/
Centers for Disease Control and Prevention (CDC). (2024, May 15). About insulin resistance and type 2 diabetes. Diabetes. https://www.cdc.gov/diabetes/about/insulin-resistance-type-2-diabetes.html
Cleveland Clinic. (2025, March 4). Side effects of metformin: Watch out for these signs. Cleveland Clinic. https://health.clevelandclinic.org/side-effects-of-metformin
NURS FPX 4015 Assessment 5 Comprehensive Head-to-Toe Assessment
Mayo Clinic. (2024). Atorvastatin (oral route) description and brand names. www.mayoclinic.org. https://www.mayoclinic.org/drugs-supplements/atorvastatin-oral-route/description/drg-20067003
Yachmaneni, A., Jajoo, S., Mahakalkar, C., Kshirsagar, S., & Dhole, S. (2023). A comprehensive review of the vascular consequences of diabetes in the lower extremities: Current approaches to management and evaluation of clinical outcomes. Cureus, 15(10). https://doi.org/10.7759/cureus.47525
Yang, Y., Zhao, B., Wang, Y., Lan, H., Liu, X., Hu, Y., & Cao, P. (2025). Diabetic neuropathy: Cutting-edge research and future directions. Signal Transduction and Targeted Therapy, 10(1). https://doi.org/10.1038/s41392-025-02175-1